Robert D. Schaller

Robert D. Schaller

Auto-generated profile, based on publicly available information

Robert D. Schaller

Section of Cardiac Electrophysiology, Cardiovascular Division, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in JAMA Cardiology
Verified
Journal Article
Open access
PDF file
RSRobert D. Schaller
Robert D. Schaller
TBTamara Brunker
Tamara Brunker
MRMichael P. Riley
Michael P. Riley
FMFrancis E. Marchlinski
Francis E. Marchlinski
SNSaman Nazarian
Saman Nazarian
HLHarold Litt
Harold Litt
Magnetic resonance imaging (MRI) remains the test of choice for many conditions owing to its safety profile and excellent soft tissue contrast without associated exposure to iodinated contrast or ionizing radiation.1 One estimate is that 50% to 75% of patients with cardiac implantable electronic devices (CIEDs) will have an indication for MRI during their lifetime.2 While the development of MRI-conditional devices has the potential to enhance access to MRI for patients with such devices, there are a large number of patients with nonconditional or legacy devices. Recent data suggesting safety of scanning patients with these devices3-5 has led to supportive specialty society guidelines and expert consensus documents, as well as changes in Centers for Medicare & Medicaid Services (CMS) reimbursement policies for MRI in patients with legacy CIED systems.6-8 However, abandoned leads, which are theoretically associated with higher risk to adjacent structures including functional leads due to greater lead tip heating compared with leads attached to a generator,9 remain a contraindication to MRI examination in many institutions and are excluded from CMS reimbursement due to a paucity of safety data.

1 November 2024 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Open access
MJMarek Jastrzębski
Marek Jastrzębski
PFPaul Foley
Paul Foley
BCBadrinathan Chandrasekaran
Badrinathan Chandrasekaran
ZWZachary Whinnett
Zachary Whinnett
PVPugazhendhi Vijayaraman
Pugazhendhi Vijayaraman
BHBengt Herweg
Bengt Herweg
BACKGROUND: Left bundle branch area pacing (LBBAP) may be an alternative to biventricular pacing (BVP) for cardiac resynchronization therapy (CRT). We sought to compare the acute hemodynamic and ECG effects of LBBAP, BVP, and left bundle-optimized therapy CRT (LOT-CRT) in CRT candidates with advanced conduction disease. METHODS: In this multicenter study, 48 patients with either nonspecific interventricular conduction delay (n=29) or left bundle branch block (n=19) underwent acute hemodynamic testing to determine the change in left ventricular pressure maximal first derivative (LV d P /d t max ) from baseline atrial pacing to BVP, LBBAP, or LOT-CRT. RESULTS: Atrioventricular-optimized increases in LV d P /d t max for LOT-CRT (mean, 25.8% [95% CI, 20.9%–30.7%]) and BVP (26.4% [95% CI, 20.2%–32.6%]) were greater than unipolar LBBAP (19.3% [95% CI, 15.0%–23.7%]) or bipolar LBBAP (16.4% [95% CI, 12.7%–20.0%]; P ≤0.005). QRS shortening was greater in LOT-CRT (29.5 [95% CI, 23.4–35.6] ms) than unipolar LBBAP (11.9 [95% CI, 6.1–17.7] ms), bipolar LBBAP (11.7 ms [95% CI, 6.4–17.0]), or BVP (18.5 [95% CI, 11.0–25.9] ms), all P ≤0.005. Compared with patients with left bundle branch block, patients with interventricular conduction delay experienced less QRS reduction ( P =0.026) but similar improvements in LV d P /d t max ( P =0.29). Bipolar LBBAP caused anodal capture in 54% of patients and resulted in less LV d P /d t max improvement than unipolar LBBAP (18.6% versus 23.7%; P <0.001). Subclassification of LBBAP capture (European Heart Rhythm Association criteria) indicated LBBAP or LV septal pacing in 27 patients (56%) and deep septal pacing in 21 patients (44%). The hemodynamic benefit of adding left ventricular coronary vein pacing to LBBAP depended on baseline QRS duration ( P =0.031) and success of LBBAP ( P <0.004): LOT-CRT provided 14.5% (5.0%–24.1%) greater LV d P /d t max improvement and 20.8 (12.8–28.8) ms greater QRS shortening than LBBAP in subjects with QRS ≥171 ms and deep septal pacing capture type. CONCLUSIONS: In a CRT cohort with advanced conduction disease, LOT-CRT and BVP provided greater acute hemodynamic benefit than LBBAP. Subjects with wider QRS or deep septal pacing are more likely to benefit from the addition of a left ventricular coronary vein lead to implement LOT-CRT. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04905290.

1 December 2017 in Heart Rhythm
Verified
Journal Article
Closed access
MSMouhannad M. Sadek
Mouhannad M. Sadek
JCJoshua M. Cooper
Joshua M. Cooper
DFDavid S. Frankel
David S. Frankel
PSPasquale Santangeli
Pasquale Santangeli
AEAndrew E. Epstein
Andrew E. Epstein
RSRobert D. Schaller
Robert D. Schaller

29 September 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
JGJames K. Gabriels
James K. Gabriels
RSRobert D Schaller
Robert D Schaller
EKElana Koss
Elana Koss
BRBruce J Rutkin
Bruce J Rutkin
RCRoger G Carrillo
Roger G Carrillo
LELaurence M Epstein
Laurence M Epstein
Clinically significant tricuspid regurgitation (TR) has historically been managed with either medical therapy or surgical interventions. More recently, percutaneous trans-catheter tricuspid valve (TV) replacement and tricuspid trans-catheter edge-to-edge repair have emerged as alternative treatment modalities. Patients with cardiac implantable electronic devices (CIEDs) have an increased incidence of TR. Severe TR in this population can occur for multiple reasons but most often results from the interactions between the CIED lead and the TV apparatus. Management decisions in patients with CIED leads and clinically significant TR, who are undergoing evaluation for a percutaneous TV intervention, need careful consideration as a trans-venous lead extraction (TLE) may both worsen and improve TR severity. Furthermore, given the potential risks of ‘jailing’ a CIED lead at the time of a percutaneous TV intervention (lead fracture and risk of subsequent infections), consideration should be given to performing a TLE prior to a percutaneous TV intervention. The purpose of this ‘state-of-the-art’ review is to provide an overview of the causes of TR in patients with CIEDs, discuss the available therapeutic options for patients with TR and CIED leads, and advocate for including a lead management specialist as a member of the ‘heart team’ when making treatment decisions in patients TR and CIED leads.

5 August 2020 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
TMTimothy M. Markman
Timothy M. Markman
TPTheodore Plappert
Theodore Plappert
AAAlejandro De Feria Alsina
Alejandro De Feria Alsina
MLMichael Levin
Michael Levin
NANigel Amankwah
Nigel Amankwah
DFDavid S. Frankel
David S. Frankel

1 November 2018 in Heart Rhythm
Verified
Journal Article
Closed access
RSRobert D. Schaller
Robert D. Schaller
MSMouhannad M. Sadek
Mouhannad M. Sadek
JCJoshua M. Cooper
Joshua M. Cooper